Last reviewed · How we verify
GnRH antagonist depot Degarelix — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
GnRH antagonist depot Degarelix (GnRH antagonist depot Degarelix) — Bioroma.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| GnRH antagonist depot Degarelix TARGET | GnRH antagonist depot Degarelix | Bioroma | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- GnRH antagonist depot Degarelix CI watch — RSS
- GnRH antagonist depot Degarelix CI watch — Atom
- GnRH antagonist depot Degarelix CI watch — JSON
- GnRH antagonist depot Degarelix alone — RSS
Cite this brief
Drug Landscape (2026). GnRH antagonist depot Degarelix — Competitive Intelligence Brief. https://druglandscape.com/ci/gnrh-antagonist-depot-degarelix. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab